Understanding High-Dose Rate (HDR) Brachytherapy: Procedure and Clinical Application
High-dose rate (HDR) brachytherapy is a specialized form of internal radiation therapy that delivers a concentrated, potent dose of radiation directly to a tumor site using a temporary radioactive source. According to the National Cancer Institute, the procedure typically involves the temporary placement of radioactive material inside the body, allowing clinicians to target malignant cells while sparing surrounding healthy tissue.
How HDR Brachytherapy Treatments Work
Unlike permanent seed implants, HDR brachytherapy uses a computer-controlled machine called an afterloader to guide a single, high-intensity radioactive source—usually Iridium-192—through thin tubes or catheters placed in or near the tumor. The Radiological Society of North America notes that the source remains in the treatment area for only a few minutes before being retracted into the device. Because the dose is delivered at a high rate, the entire treatment session is brief, often lasting about 15 minutes.
Treatment Frequency and Scheduling
The total number of sessions depends on the specific cancer diagnosis and the treatment protocol determined by the oncology team. While some conditions may be managed with one or two treatments, others require a series of sessions over several days or weeks. If a patient requires a second treatment, it is typically scheduled for a separate day to allow for optimal anatomical positioning and tissue recovery. The American Society for Radiation Oncology emphasizes that these schedules are individualized to balance tumor control with the preservation of organ function.
Comparing HDR and LDR Brachytherapy
Brachytherapy is generally categorized into Low-Dose Rate (LDR) and High-Dose Rate (HDR) approaches. The primary differences are outlined below:
| Feature | Low-Dose Rate (LDR) | High-Dose Rate (HDR) |
|---|---|---|
| Radiation Delivery | Continuous, low intensity | Short, high intensity |
| Duration | Days (often requires hospital stay) | Minutes (often outpatient) |
| Source Type | Permanent seeds or temporary | Temporary source |
What Patients Should Expect
Before the radiation source is introduced, patients undergo a planning phase where imaging—such as CT, MRI, or ultrasound—is used to map the precise location of the tumor. This ensures the catheters are positioned accurately. Once the treatment is complete, the radioactive source is removed, meaning no radiation remains in the patient’s body after the session. According to the Cancer Research UK, this approach significantly reduces the risk of radiation exposure to family members or caregivers compared to permanent implants.
Clinical Considerations and Safety
The efficacy of HDR brachytherapy relies on the precision of catheter placement. Because the radiation source is highly concentrated, the oncology team monitors the dose distribution carefully to minimize side effects, which may include localized swelling, irritation, or fatigue. Patients are encouraged to discuss their specific treatment plan, including the expected number of sessions and potential side effects, with their radiation oncologist to ensure they understand the goals of the therapy.
Keep reading